Right vein, first time, every time.
MAKING SIMPLE PROCEDURES SIMPLE
We're on a mission to improve the cannulation experience on both sides of the needle. Cannulation is often the first key procedural step in a patient's clinical care journey, but it's frequently filled with fear as clinicians often fail to find the right vein the first time. This can lead to pain, anxiety, complications, and delayed treatments. We're currently in product development to bring this concept to life and solve this painful problem for patients and health care providers around the world.
After coming together though and winning the Perth Biodesign program in 2019, Nikhilesh Bappoo, Nicholas Buckley & Dr Katherine Arenson have been pushing forward with their award winning design concept. With their bench prototype completed and alpha prototype in development, VeinTech are positioned to solve a common pain-point in health care around the world: the high rate of first pass cannulation failure rates. With their ultra portable hand held vein imaging device, the VeinWave, they aim to help clinicians successfully target the right vein, first time, every time.
2019 OVERALL WINNER
2020 INNOVATION VOUCHER
2020 INNOVATION AWARDS FINALIST
2021 ASIA-PACIFIC WINNER
2021 WA MTP MANUFACTURING VOUCHER
"Every time I ask my nursing staff what their biggest problem is and what I can do to help, it is always cannulation."
PROF. FIONA WOOD AM
Since the advent of intravenous cannulas in the 1950’s, clinicians have used subjective judgement through visual examination and manual palpation to estimate the location and quality of veins to target with a needle for cannulation. 70 years on, the average insertion failure rate is still 40%, and up to 70% in individuals with difficult intravenous access (DIVAs) such as children, chemotherapy and obese patients. These unnecessary failures results in pain and stress for both patients and clinicians, increasing the risk of complications and delaying care.
INPATIENTS REQUIRE A CANNULA
FAIL ON FIRST INSERTION ATTEMPT
COST PER MISSED ATTEMPT
DIVAS EST. COST TO GLOBAL HEALTHCARE
VeinWave is a handheld ultraportable unit designed to assist with visualising veins to target for cannulation. It is designed to minimize training requirements and cost, therefore allowing for widespread adoption.
VeinWave aims to significantly reduce the first-pass failure rate of 40%. By finding the right veins faster, we envision better patient satisfaction, lower risks of complications and improved clinical efficiency.
In Australia alone, 10 million cannulas fail on first insertion every year, resulting in an AU$700 million burden. With a global increasing trend of chronic disease and obesity, the failure rate continues to grow, representing a significant market opportunity for VeinTech and the VeinWave technology.
EASY TO USE
OUR GENEROUS SUPPORTERS
We're grateful to receive support from the following organisations